Join the limbic and Melanoma Institute Australia in a case-study based discussion of breakthrough melanoma trials – including those most recently unveiled at ASCO 2020 – and what they mean for clinical practice in Australia.
There will be an opportunity to ask the panel questions during the webinar. Alternatively, you can submit your questions to [email protected] before the event.
Wednesday, 1st July 2020, 7:00pm – 8:00pm (AEST)
Note: A reminder email will be sent when the webinar is about to begin
Professor Georgina Long AO: Co-Medical Director of Melanoma Institute Australia (MIA)
Chair, Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, The University of Sydney.
With Special Guests:
Associate Professor Victoria Atkinson: School of Clinical Medicine, the University of Queensland and Medical Oncologist, the Princess Alexandra and Greenslopes Private Hospitals, Brisbane.
Associate Professor David Gyorki: Consultant surgeon, the Peter MacCallum Cancer Centre and Olivia Newton John Cancer Centre.
Professor Angela Hong. Radiation oncologist at Melanoma Institute Australia.
This webinar is an independent initiative of the limbic in collaboration with Melanoma Institute Australia (MIA).
Thank you to Bristol Myers Squibb Australia Pty Ltd for providing the financial support that made this webinar possible.